The Association Between Physical Activity Level and Post-operative Prognosis
Not yet recruiting
- Conditions
- Elective Operation Patients
- Interventions
- Behavioral: preoperative physical activity level within 3 months
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 324
- Registration Number
- NCT06413329
68Ga-NOTA-RM26 PET/CT in Glioma Patients
Early Phase 1
Recruiting
- Conditions
- Glioma
- Interventions
- Drug: 68Ga-RM26
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06412952
- Locations
- 🇨🇳
Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing, Beijing, China
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06411678
- Locations
- 🇨🇳
PUMCH, Dongcheng, Beijing, China
Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage
Not Applicable
Recruiting
- Conditions
- Lung Cancer
- Interventions
- Device: Valve-regulated pleural drainage system
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06410716
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4
Recruiting
- Conditions
- Pediatric ALLSjogren's Syndrome
- Interventions
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06410833
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.
Early Phase 1
Recruiting
- Conditions
- Duchenne Muscular Dystrophy (DMD)
- Interventions
- Genetic: GEN6050X intravenous injection
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 3
- Registration Number
- NCT06392724
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
Phase 2
Recruiting
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: Immune checkpoint inhibitor
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT06388031
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Borderline Resectable Pancreatic Cancer
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT06387810
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
Not Applicable
Recruiting
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06387823
- Locations
- 🇨🇳
Luoyang Central Hospital, Luoyang, Henan, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Yanan University Affiliated Hospital, Yanan, Shaanxi, China
Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia
Recruiting
- Conditions
- Sarcopenia
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT06380777
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath